Images From CROI: Click on image to enlarge 40-foot-tall, 10,000-pound bear sculpture in front of Colorado Convention Center in Denver Matthias Egger, M.D. Jason Flamm, M.D. Roy M. Gulick, M.D., M.P.H. Welcome reception in the huge poster hall featured large screen TV screens and "jumbotrons" for football fans Cal Cohen, M.D. Reception in the poster room Julie Davids, Executive Director, Community HIV/AIDS Mobilization Project Packed HIV prevention session caused overflow into hallway Pablo Tebas, M.D. Many people in crowded sessions sat outside watching session on screens Ben Young, M.D., Ph.D.

At the 13th Conference on Retroviruses and Opportunistic Infections (CROI 2006), our correspondents asked 18 HIV clinicians, researchers and advocates to share their thoughts on the same question: What do you feel is the most important news to come out of CROI 2006? Here's what they had to say.

Clinicians and Researchers

• Cal Cohen, M.D.
  SMART study investigator; Research Director, Community Research Initiative of New England
  (Dr. Cohen discusses the SMART study, atazanavir monotherapy and integrase inhibitors.)
  Listen (5.2MB MP3, 5:45)
  Read interview

• Ruth E. Dickover, Ph.D.
  Associate Research Specialist, David Geffen School of Medicine, University of California-Los Angeles
  (Dr. Dickover discusses the potential for male circumcision to protect women from HIV.)
  Listen (4MB MP3, 4:19)
  Read interview

• Matthias Egger, M.D.
  University of Berne, Switzerland; University of Bristol, United Kingdom
  (Dr. Egger discusses the CDC proposal to make HIV testing in the U.S. part of everyone's medical visit and the ramifications of the SMART study.)
  Listen (1.3MB MP3, 1:25)
  Read interview

• Jason Flamm, M.D.
  Attending Physician, Kaiser Permanente Medical Group, Sacramento, California
  (Dr. Flamm discusses the SMART study and the pros/cons of HIV treatment.)
  Listen (1.4MB MP3, 1:32)
  Read interview

• Roy M. Gulick, M.D., M.P.H.
  Associate Professor of Medicine, Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York
  (Dr. Gulick discusses antiretrovirals in development and quadruple-NRTI therapy.)
  Listen (2.4MB MP3, 2:33)
  Read interview

• Annmarie Pacchia, Ph.D.
  Research Teaching Specialist, Robert Wood Johnson Medical School, Piscataway, N.J.
  (Dr. Pacchia discusses antiretrovirals in development, latent HIV and women-specific research.)
  Listen (3MB MP3, 3:17)
  Read interview

• Dr. Eeva Salo
  Infectious Disease Pediatrician, Hospital for Infants and Children, University of Helsinki, Finland
  (Dr. Salo discusses the growing number of studies from Africa.)
  Listen (1.3MB MP3, 1:23)
  Read interview

• Paul Sax, M.D.
  HIV Program Director, Brigham and Women's Hospital; Assistant Professor, Harvard Medical School, Boston, Mass.
  (Dr. Sax discusses antiretrovirals in development, including PA-457, integrase inhibitors and TMC114.)
  Listen (2.3MB MP3, 2:30)
  Read interview

• Pablo Tebas, M.D.
  Principal Investigator, AIDS Clinical Trial Unit, University of Pennsylvania; Associate Professor of Medicine, University of Pennsylvania School of Medicine
  (Dr. Tebas discusses the SMART trial, integrase inhibitors and male circumcision.)
  Listen (3MB MP3, 3:10)
  Read interview

• Mark Wainberg, Ph.D.
  Director, McGill AIDS Center, Montreal, Quebec, Canada
  (Dr. Wainberg discusses the SMART study and enrollment in treatment interruption trials.)
  Listen (1.8MB MP3, 1:31)
  Read interview

• Tom Wilkinson, Ph.D.
  Post-Graduate Researcher, University of California-Los Angeles
  (Dr. Wilkinson discusses integrase inhibitors and maturation inhibitors.)
  Listen (2.7MB MP3, 3:03)
  Read interview

• Ben Young, M.D., Ph.D.
  Attending Physician, Denver ID Consultants at Rose Medical Center, Denver, Colo.
  (Dr. Young discusses incidence of renal toxicity among patients on tenofovir.)
  Listen (1.9MB MP3, 2:00)
  Read interview

• Xu Yu, M.D.
  Instructor, Partners AIDS Research Center, Massachusetts General Hospital, Boston, Mass.
  (Dr. Xu discusses developments regarding vaccine design.)
  Listen (1.6MB MP3, 1:44)
  Read interview

Activists and Educators

• Julie Davids
  Executive Director, Community HIV/AIDS Mobilization Project, New York
  (Ms. Davids discusses the "next generation" of HIV prevention, including microbicides and tenofovir.)
  Listen (2.6MB MP3, 2:47)
  Read interview

• Bob Munk, Ph.D.
  Coordinator, AIDS InfoNet, New Mexico
  (Mr. Munk discusses treatment interruptions, integrase inhibitors and atazanavir monotherapy.)
  Listen (1.7MB MP3, 1:47)
  Read interview

Graduate Students

• Mark Biscone
  Graduate Student, University of Pennsylvania School of Medicine, Philadelphia, Pa.
  (Mr. Biscone discusses antiretrovirals in development.)
  Listen (1.5MB MP3, 1:36)
  Read interview

• Judith Mandl
  Graduate Student in Population Biology, Ecology, and Evolution, Emory University, Atlanta, Ga.
  (Ms. Mandl discusses T-cell depletion in mucosal tissues.)
  Listen (1.2MB MP3, 1:14)
  Read interview

• Malavika Srinivasan-Giri
  Graduate Student in Immunology, Wistar Institute, Philadelphia, Pa.
  (Ms. Giri discusses pathogenesis and microbicides.)
  Listen (1.2MB MP3, 1:16)
  Read interview